A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

1995312 citationsJournal Articlebronze Open Access

Authors

Antiretroviral therapy administered during primary HIV infection may improve the subsequent clinical course and increase the CD4 cell count.

Good health and well-being

Published in: New England Journal of Medicine

Volume 333, Issue 7, pp. 408-413

Field-Weighted Citation Impact: 10.15